drugset / Trial / NCT04150770
A Clinical Trial of Infliximab for Childhood Uveitis
NaSingle-groupOpen-labelTreatment
Summary
This project is designed to test the hypothesis that infliximab is clinically useful for patients with refractory childhood uveitis.
Timeline
- Start
- 2017-01
- Primary completion
- 2020-01
- Completion
- 2022-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Infliximab | Monoclonal antibody | 5 mg/kg | Intravitreal |